RMTI
Rockwell Medical Inc
NASDAQ: RMTI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.88
-2.56% today
Updated 2026-04-30
Market cap
$35.07M
P/E ratio
—
P/S ratio
0.51x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
Rockwell Medical Inc (RMTI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-7.67%
Operating margin
-2.17%
ROE
-15.30%
ROA
-5.04%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $28.64M | $-4.57M | 9.78% | -16.19% | -15.97% |
| 2007 | $43.05M | $-3.72M | 7.04% | -8.38% | -8.64% |
| 2008 | $51.67M | $-7.86M | 5.84% | -15.65% | -15.22% |
| 2009 | $54.73M | $-5.50M | 14.41% | -10.02% | -10.05% |
| 2010 | $59.55M | $-2.68M | 16.56% | -4.82% | -4.51% |
| 2011 | $48.97M | $-21.44M | 11.52% | -44.29% | -43.79% |
| 2012 | $49.84M | $-54.02M | 13.43% | -108.87% | -108.38% |
| 2013 | $52.38M | $-48.78M | 12.71% | -89.84% | -93.13% |
| 2014 | $54.19M | $-21.33M | 15.77% | -32.40% | -39.36% |
| 2015 | $55.35M | $-14.42M | 16.15% | -27.28% | -26.05% |
| 2016 | $53.28M | $-19.80M | 12.67% | -37.93% | -37.16% |
| 2017 | $57.30M | $-25.92M | 6.46% | -45.24% | -45.24% |
| 2018 | $63.39M | $-32.13M | -2.50% | -51.18% | -50.68% |
| 2019 | $61.30M | $-34.13M | 4.63% | -55.62% | -55.67% |
| 2020 | $62.20M | $-30.89M | 4.38% | -45.69% | -49.66% |
| 2021 | $61.93M | $-32.67M | -3.91% | -48.98% | -52.76% |
| 2022 | $72.81M | $-18.68M | 5.60% | -23.05% | -25.65% |
| 2023 | $83.61M | $-8.44M | 10.41% | -7.98% | -10.09% |
| 2024 | $101.49M | $-480000.00 | 17.23% | 0.60% | -0.47% |
| 2025 | $69.26M | $-5.31M | 16.89% | -6.77% | -7.67% |